Indaptus Therapeutics is trading 5.29% higher at $3.48 in after-hours trading, with no clear company-specific announcement identified to explain the move.

  • The October 27 regular-session close was $3.31; shares ended the session down 1.05%.
  • The previously reported private placement is earlier news, not a confirmed catalyst for the after-hours move.
  • Broader indexes rose during the session, but available information does not establish a link to the stock’s after-hours gain.